Alexithymia in Ankylosing Spondylitis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ankylosing Spondylitis
- Sponsor
- Istanbul Medeniyet University
- Enrollment
- 110
- Locations
- 1
- Primary Endpoint
- Alexithymia rate in AS patients and controls according to Toronto Alexithymia Scale-20
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The study included 55 patients having Ankylosing Spondylitis (AS) for at least 1 year diagnosed according to the ASAS classification criteria who presented to our hospital's outpatient clinic and 55 healthy subjects. Demographic data were recorded for 55 AS patients who were subsequently assessed using the BASMI (Bath Ankylosing Spondylitis Metrology Index) in terms of elasticity and spinal mobility as well as the BASFI (Bath Ankylosing Spondylitis Functional Index) to determine functional status, the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) to assess the disease activity and the ASQoL (Ankylosing Spondylitis Quality of Life Questionnaire) to evaluate quality of life. The Toronto Alexithymia Scale-20 (TAS-20) was used for assessment of alexithymia and Beck's Depression Inventory (BDI) for depression among patients.
Detailed Description
The study included 55 patients having Ankylosing Spondylitis (AS) for at least 1 year diagnosed according to the ASAS classification criteria who presented to our hospital's outpatient clinic and 55 healthy subjects. Demographic data were recorded for 55 AS patients who were subsequently assessed using the BASMI (Bath Ankylosing Spondylitis Metrology Index) in terms of elasticity and spinal mobility as well as the BASFI (Bath Ankylosing Spondylitis Functional Index) to determine functional status, the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) to assess the disease activity and the ASQoL (Ankylosing Spondylitis Quality of Life Questionnaire) to evaluate quality of life. The Toronto Alexithymia Scale-20 (TAS-20) was used for assessment of alexithymia and Beck's Depression Inventory (BDI) for depression among patients.
Investigators
Bilinç Doğruöz Karatekin
MD, Research Assistant of PMR
Istanbul Medeniyet University
Eligibility Criteria
Inclusion Criteria
- •Diagnosed as AS for at least 1 year according to the ASAS classification criteria
- •over 18 years old
Exclusion Criteria
- •fibromyalgia
- •age less than 18 years
- •vision and hearing impairment
- •neurological disease (Parkinson's disease, multiple sclerosis, cerebrovascular disease),
- •history of a psychiatric disorder (schizophrenia, bipolar disorder)
- •history of chronic condition (DM, thyroid disease) or malignancy
Outcomes
Primary Outcomes
Alexithymia rate in AS patients and controls according to Toronto Alexithymia Scale-20
Time Frame: 7 months
Depression rate in AS patients and controls according to Beck Depression Inventory
Time Frame: 7 months
Relationship between alexithymia and depression and functional indexes (BASFI, BASMI, BASDAI, ASQoL)
Time Frame: 7 months